Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.

Kang KM, Lee JM, Shin CI, Baek JH, Kim SH, Yoon JH, Han JK, Choi BI.

J Magn Reson Imaging. 2013 Sep;38(3):555-63. doi: 10.1002/jmri.24022. Epub 2013 Feb 6.

PMID:
23390008
[PubMed - indexed for MEDLINE]
2.

Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.

Yoon LS, Catalano OA, Fritz S, Ferrone CR, Hahn PF, Sahani DV.

J Comput Assist Tomogr. 2009 May-Jun;33(3):363-8. doi: 10.1097/RCT.0b013e3181852193.

PMID:
19478628
[PubMed - indexed for MEDLINE]
3.

Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.

Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, Crippa S, Capelli P, Salvia R, Pozzi Mucelli R.

Radiology. 2009 Oct;253(1):106-15. doi: 10.1148/radiol.2531080604. Epub 2009 Jul 31.

PMID:
19703865
[PubMed - indexed for MEDLINE]
4.

Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.

Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T.

Pancreas. 2009 Jan;38(1):8-16. doi: 10.1097/MPA.0b013e318181b90d.

PMID:
18665010
[PubMed - indexed for MEDLINE]
5.

Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.

Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI.

Radiology. 2014 Feb;270(2):444-53. doi: 10.1148/radiol.13122712. Epub 2013 Oct 28.

PMID:
24126370
[PubMed - indexed for MEDLINE]
6.

Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.

Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF.

Radiology. 2006 Feb;238(2):560-9.

PMID:
16436817
[PubMed - indexed for MEDLINE]
7.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

PMID:
15166958
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.

Jang KM, Kim SH, Lee SJ, Park HJ, Choi D, Hwang J.

Radiology. 2013 Feb;266(2):491-501. doi: 10.1148/radiol.12121106. Epub 2012 Dec 13.

PMID:
23238154
[PubMed - indexed for MEDLINE]
9.

Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.

Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.

Am J Surg Pathol. 2008 Feb;32(2):243-55. doi: 10.1097/PAS.0b013e3181484f1e.

PMID:
18223327
[PubMed - indexed for MEDLINE]
10.

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.

Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

PMID:
24280573
[PubMed - indexed for MEDLINE]
11.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
[PubMed - indexed for MEDLINE]
12.

Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.

Kang MJ, Lee KB, Jang JY, Kwon W, Park JW, Chang YR, Kim SW.

Pancreas. 2013 Nov;42(8):1267-74.

PMID:
24308063
[PubMed - indexed for MEDLINE]
13.

Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.

Kim J, Jang KT, Mo Park S, Lim SW, Kim JH, Lee KH, Lee JK, Heo JS, Choi SH, Choi DW, Rhee JC, Lee KT.

Tumour Biol. 2011 Jun;32(3):535-42. doi: 10.1007/s13277-010-0148-z. Epub 2010 Dec 30.

PMID:
21190101
[PubMed - indexed for MEDLINE]
14.

Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.

Hwang DW, Jang JY, Lim CS, Lee SE, Yoon YS, Ahn YJ, Han HS, Kim SW, Kim SG, Yun YK, Han SS, Park SJ, Lim TJ, Kang KJ, Sim MS, Choi SH, Heo JS, Choi DW, Hur KY, Lee DS, Yun SS, Kim HJ, Cho CK, Kim HJ, Yu HC, Cho BH, Song IS.

J Korean Med Sci. 2011 Jun;26(6):740-6. doi: 10.3346/jkms.2011.26.6.740. Epub 2011 May 18.

PMID:
21655058
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.

Castelli F, Bosetti D, Negrelli R, Di Paola V, Zantedeschi L, Ventriglia A, Manfredi R, Mucelli RP.

Radiol Med. 2013 Sep;118(6):917-29. doi: 10.1007/s11547-013-0945-8. Epub 2013 Jun 26.

PMID:
23801393
[PubMed - indexed for MEDLINE]
16.

Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

Xu B, Ding WX, Jin DY, Wang DS, Lou WH.

World J Gastroenterol. 2013 Mar 7;19(9):1451-7. doi: 10.3748/wjg.v19.i9.1451.

PMID:
23539521
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F.

Ann Surg. 2011 Dec;254(6):971-6. doi: 10.1097/SLA.0b013e3182383137.

PMID:
22076067
[PubMed - indexed for MEDLINE]
18.

Utility of multidetector row CT in diagnosing branch duct IPMNs of the pancreas compared with MR cholangiopancreatography and endoscopic ultrasonography.

Arikawa S, Uchida M, Uozumi J, Sakoda J, Kaida H, Kunou Y, Hirose Y, Abe T, Hayabuchi N, Naito Y, Okabe Y, Suga H, Kinoshita H.

Kurume Med J. 2011;57(4):91-100.

PMID:
21778670
[PubMed - indexed for MEDLINE]
Free Article
19.

Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.

Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, Fukuda H, Takahashi S.

Ann Nucl Med. 2011 Aug;25(7):501-10. doi: 10.1007/s12149-011-0494-y. Epub 2011 May 3.

PMID:
21537945
[PubMed - indexed for MEDLINE]
20.

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, Ishida T, Takano Y, Tanaka S, Takenaka A.

Gut. 2008 Nov;57(11):1561-5. doi: 10.1136/gut.2007.145631. Epub 2008 May 13.

PMID:
18477671
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk